Evidence map›Paper›PMID 28947536›Full record

ArticleDevelopment (Cambridge, England)2017

Pluripotent stem cell differentiation reveals distinct developmental pathways regulating lung- versus thyroid-lineage specification.

Maria Serra, Konstantinos-Dionysios Alysandratos, Finn Hawkins, Katherine B McCauley, Anjali Jacob, Jinyoung Choi, Ignacio S Caballero, Marall Vedaie, Anita A Kurmann, Laertis Ikonomou and 3 more

Open access · greenAbstract read
In one paragraph

Article in Development (Cambridge, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Long isoforms of the COPD risk gene FAM13A orchestrate human lung epithelial development.American journal of respiratory cell and molecular biology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Maria SerraCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA 02118, USA.ORCID 0000-0002-9885-8093
Konstantinos-Dionysios AlysandratosCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA 02118, USA.
Finn HawkinsCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA 02118, USA.
Katherine B McCauleyCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA 02118, USA.
Anjali JacobCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA 02118, USA.
Jinyoung ChoiDivision of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA 02215, USA.
Ignacio S CaballeroCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA 02118, USA.
Marall VedaieCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA 02118, USA.
Anita A KurmannDivision of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA 02215, USA.
Laertis IkonomouCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA 02118, USA.
Anthony N HollenbergDivision of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA 02215, USA.
John M ShannonDivision of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA john.shannon@cchmc.org dkotton@bu.edu.
Darrell N KottonCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA 02118, USA john.shannon@cchmc.org dkotton@bu.edu.ORCID 0000-0002-9604-8476
Boston University · USBeth Israel Deaconess Medical Center · USCincinnati Children's Hospital Medical Center · US

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
Editing Alveolar Progenitor Cells for Correction of Monogenic DiseaseU01HL134745 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI KOTTON, DARRELL N., MORRISEY, EDWARD E · 2016 to 2022
$8.3M
Derivation of Transplantable Lung Epithelial Progenitors from iPS CellsR01HL095993 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton · 2009 to 2026
$7.5M
"Lung MAP" Atlas Research CenterU01HL122642 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI POTTER, S. STEVEN, WHITSETT, JEFFREY A · 2014 to 2018
$3.9M
Thyroid Follicular Cell Signaling and Development in HumansR01DK105029 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI ANTHONY N HOLLENBERG, Darrell N. Kotton · 2016 to 2026
$3.7M
Bioengineering of Transplantable Humanized Lungs from iPS CellsR01HL108678 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOTTON, DARRELL N., VACANTI, JOSEPH P · 2011 to 2014
$2.8M
Epigenenomic and transcriptomic networks in normal and defective lung developmentR01HL128172 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOTTON, DARRELL N. · 2015 to 2018
$2.2M
Defining the genetic program of primordial lung progenitorsR01HL111574 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI IKONOMOU, LAERTIS · 2012 to 2016
$2.1M
LPCAT1 is essential for perinatal lung function and survivalR01HL098319 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI SHANNON, JOHN M · 2010 to 2013
$1.9M
iPSC Modeling of the Role of NKX2-1 in Human Lung Development and DiseaseR01HL122442 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOTTON, DARRELL N. · 2014 to 2017
$1.6M
Biomechanical determinants of lung cell fate in pluripotent stem cellsR01HL124280 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI IKONOMOU, LAERTIS, WONG, JOYCE Y · 2014 to 2017
$1.6M
NCATS NIH HHS UL1 TR001430NHLBI NIH HHS R01 HL095993NHLBI NIH HHS R01 HL098319NHLBI NIH HHS R01 HL108678NHLBI NIH HHS R01 HL111574NHLBI NIH HHS R01 HL122442NHLBI NIH HHS R01 HL128172NHLBI NIH HHS U01 HL122642NHLBI NIH HHS U01 HL134745NIDDK NIH HHS R01 DK105029
6 · The paper itself

Abstract

The

Indexed as

Body PatterningCell DifferentiationSignal TransductionAnimalsBiomarkersBone Morphogenetic ProteinsCell LineageEmbryo, MammalianEmbryonic DevelopmentEndodermEpithelial CellsFibroblast Growth FactorsGene Expression ProfilingGene Expression Regulation, DevelopmentalGreen Fluorescent ProteinsHomeodomain ProteinsBiomarkersBone Morphogenetic ProteinsFibroblast Growth FactorsGreen Fluorescent ProteinsHomeodomain ProteinsWnt ProteinsEmbryoEndodermLungNkx2-1Pluripotent stem cellsThyroid

Identifiers

PMID28947536
PMCPMC5702071
OpenAlexW2759156549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.